Crossmark

Serotype independent protection induced by a vaccine based on the IgM protease of Streptococcus suis and proposal for a new immunity-based classification system

Crossref DOI link: https://doi.org/10.1186/s40813-024-00398-2

Published Online: 2024-10-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jacobs, A. A. C.

Grommen, A. W. F.

Badbanchi, S.

van Hout, A. J.

van Kasteren-Westerneng, T. J.

Morales, L. Garcia

Bron, R.

Segers, R. P. A. M.
Funding

Funding for this research was provided by:

MSD Animal Health
License Information

Text and Data Mining valid from 2024-10-14

Version of Record valid from 2024-10-14
More Information

Article History

Received: 2 July 2024

Accepted: 6 October 2024

First Online: 14 October 2024

Declarations

:

: The in-vivo laboratory studies were conducted according to EU directive 2010/63/EU and the relevant Dutch legislation (Act on Animal Experimentation permit number AVD221002016561).

: All authors have read the manuscript and agreed on publication in its current version.

: All authors except AvH are employed by MSD Animal Health where a vaccine based on the rIde antigen is currently under development.

Document is current

Any future updates will be listed below